The market for robotic assisted endoscopy was estimated to be worth USD 1.84 billion worldwide in 2021 and is projected to grow at a CAGR of 15.05% during the forecast period. The main drivers of the rise include an increasing demand for minimally invasive surgical (MIS) procedures, new product approvals by regulatory agencies including the U.S. Food and Drug Administration (FDA), and the high prevalence of chronic conditions.
